ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Search result - IPro for Prolia®
Information for professionals for Prolia®:Amgen Switzerland AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
M05BX04 - DenosumabATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
 
M05 - Drugs for Treatment Of Bone Diseases

Drugs used for the treatment of bone diseases, see also:
A11CC - Vitamin D and analogues
A12A - Calcium
A12AX - Calcium, combinations with vitamin D and/or other drugs
A12CD - Fluoride
G03C/G03F - Estrogens/Progestogens and estrogens in combination
H05BA - Calcitonins

M05B - Drugs Affecting Bone Structure and Mineralization
 
M05BX - Other Drugs Affecting Bone Structure and Mineralization
 

The DDD for denosumab is based on the treatment of osteoporosis.

M05BX04 - Denosumab
DoseRoute of administrationNote
 P 
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home